Skip to main content

and
  1. Article

    Open Access

    Early combination therapy of COVID-19 in high-risk patients

    Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been observed in immunocompromised hosts. Early monotherapy with direct-acting antivirals or monoclonal antibodies, as rec...

    Hans Martin Orth, Charlotte Flasshove, Moritz Berger, Tessa Hattenhauer in Infection (2024)

  2. Article

    Open Access

    Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?

    Yannis R. Hübner, Nikolai Spuck, Moritz Berger, Stefan Schlabe in Infection (2023)

  3. Article

    Open Access

    Tecovirimat for the treatment of severe Mpox in Germany

    In May 2022, a multi-national mpox outbreak was reported in several non-endemic countries. The only licensed treatment for mpox in the European Union is the orally available small molecule tecovirimat, which in O...

    Lennart Hermanussen, Thomas Theo Brehm, Timo Wolf, Christoph Boesecke in Infection (2023)

  4. Article

    Open Access

    Severe monkeypox-virus infection in undiagnosed advanced HIV infection

    Christoph Boesecke, Malte B. Monin, Kathrin van Bremen, Stefan Schlabe in Infection (2022)

  5. Article

    Open Access

    SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness

    Malte B. Monin, Benjamin Marx, Lisa Meffert, Christoph Boesecke in Annals of Hematology (2022)